Joshua Chaim

Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers

Min Yuen Teo, Kenneth Seier, Irina Ostrovnaya et al. · Journal of Clinical Oncology · 2018 · 528 citations · Full text

Higher Response Rate, Pathology, Tumor Biology +16

Radiogenomics of Clear Cell Renal Cell Carcinoma: Associations between CT Imaging Features and Mutations

Christoph Karlo, Pier Luigi Di Paolo, Joshua Chaim et al. · Radiology · 2013 · 268 citations · Full text

Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture Analysis

Yulia Lakhman, Harini Veeraraghavan, Joshua Chaim et al. · European Radiology · 2016 · 156 citations

Tumoral Pathology, Medical Imaging, Surgical Pathology +8

Cancer Susceptibility Mutations in Patients With Urothelial Malignancies

Maria I. Carlo, Vignesh Ravichandran, Preethi Srinavasan et al. · Journal of Clinical Oncology · 2019 · 138 citations · Full text

Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors

Amishi Y. Shah, Ritesh R. Kotecha, Emily Lemke et al. · European Journal of Cancer · 2019 · 120 citations · Full text

Urology, Genitourinary Cancer, Medicine +4